4.5 Review

A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management

Related references

Note: Only part of the references are listed.
Review Engineering, Biomedical

Towards translational optogenetics

Akshaya Bansal et al.

Summary: Optogenetics is a valuable tool for studying neural circuits and therapeutic applications. Future advancements should focus on improving gene delivery vectors, developing red-shifted photoresponsive proteins, enhancing transduction of near-infrared light, and creating wireless implantable light-delivery devices.

NATURE BIOMEDICAL ENGINEERING (2023)

Article Engineering, Biomedical

Closed-loop enhancement and neural decoding of cognitive control in humans

Ishita Basu et al.

Summary: This study demonstrates that closed-loop electrical stimulation of the internal capsule can enhance cognitive control in participants with epilepsy. Decoding of task performance from electrode activity was also achieved. These findings have the potential to improve cognitive deficits in individuals with severe mental disorders.

NATURE BIOMEDICAL ENGINEERING (2023)

Review Neurosciences

Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis

Ashna Talwar et al.

Summary: This study evaluated the clinical potential of oral CBD in treating refractory epilepsy through a systematic review and meta-analysis. The results suggest that CBD treatment is more effective than placebo in reducing seizures in patients with refractory epilepsy, although it is associated with increased adverse events. CBD shows promise as a standalone or adjunct therapy for controlling seizures, but further investigation and guidelines are needed.

EXPERIMENTAL NEUROLOGY (2023)

Review Neurosciences

Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies

Doodipala Samba Reddy

Summary: This article provides an overview of the clinical utility and efficacy of cannabidiol (CBD) as a treatment for refractory and rare forms of epilepsy. CBD has shown to be a safe and effective antiseizure medicine with multiple mechanisms of action. However, there are still challenges and risks associated with its widespread use.

EXPERIMENTAL NEUROLOGY (2023)

Review Biochemistry & Molecular Biology

Polymorphisms Affecting the Response to Novel Antiepileptic Drugs

Valentina Urzi Brancati et al.

Summary: Epilepsy is a common chronic neurological disorder affecting around 1% of the global population, especially in developing countries. Although several antiepileptic drugs are available for treatment, approximately 20%-30% of patients do not achieve seizure freedom. Various factors, including genetic factors, contribute to AED-resistance. Polymorphisms in genes encoding drug transporters, drug targets in the brain, and drug metabolism enzymes can result in interindividual differences in drug response. This review highlights the influence of these single nucleotide polymorphisms (SNPs) on the pharmacokinetics, pharmacodynamics, and efficacy of new antiepileptic drugs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

CRISPR: a tool with potential for genomic reprogramming in neurological disorders

Yogesh K. Dhuriya et al.

Summary: The complexity of neural circuitry requires precise transcriptional programs, and disturbance during development may lead to neurological disorders. Inadequate understanding of pathogenic mechanisms is a major obstacle, but the CRISPR-Cas9 technology offers a promising approach for targeted correction or silencing of disease-causing mutations. This article discusses the mechanisms, limitations, and potential applications of CRISPR technology in combating neurological disorders.

MOLECULAR BIOLOGY REPORTS (2023)

Review Biochemistry & Molecular Biology

Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain

Giuseppina Crescente et al.

Summary: To alleviate orofacial pain and improve patients' quality of life, researchers and healthcare professionals are seeking new alternatives, including the use of bioactive compounds from Cannabis sativa L. These compounds, such as non-psychoactive cannabinoids, flavonoids, and terpenes, show promising effects in reducing pain intensity by acting on multiple mechanisms, including inflammation and the endocannabinoid system.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Artificial intelligence and neuroscience: An update on fascinating relationships

Nishanth Gopinath

Summary: Innovative technologies such as AI, deep learning, machine learning, and optogenetics have played a key role in accelerating discoveries in neuroscience, with AI being particularly promising. The limitations of human processing power can be overcome by leveraging AI's capabilities, allowing for advancements in neuroscience and the identification of neurological problems. This review explores the valuable relationship between AI and neuroscience and its applications in expanding our understanding of the human brain.

PROCESS BIOCHEMISTRY (2023)

Article Neurosciences

Evidence for Thalamic Responsive Neurostimulation in Treatment of Adult and Pediatric Epilepsy

Meena Vessell et al.

Summary: Responsive neurostimulation (RNS) has shown effectiveness in patients with identifiable seizure foci, but there is emerging evidence suggesting its feasibility for nonfocal or multifocal epileptic profiles with thalamic targeting. This study describes two successful implantations of thalamic RNS (tRNS) targeting the centromedian nucleus of the thalamus (CMT), along with a literature review of reported tRNS cases. The findings show promising outcomes, with significant seizure reduction in both adult and pediatric patients.

STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2023)

Article Otorhinolaryngology

Laryngology Outcomes Following Implantable Vagus Nerve Stimulation

Philip R. R. Brauer et al.

Summary: Vagus nerve stimulation (VNS) devices for treatment of epilepsy and depression have led to an increase in iatrogenic injuries to the vagus nerve, resulting in vocalization and quality of life impairments. This study analyzed adverse events reported to the FDA after VNS implantation and found that laryngeal adverse effects were relatively common, including voice alteration and vocal fold paresis/paralysis. Device problems associated with these adverse effects included high impedance, incorrect frequency delivery, and battery issues.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2023)

Review Neurosciences

The place of a ketogenic diet in the treatment of resistant epilepsy: a comprehensive review

Ebru Cicek et al.

Summary: The ketogenic diet is commonly used for the treatment of drug-resistant epilepsy, showing positive effects in seizure control and improvement in quality of life. However, the sustainability of the diet and potential side effects should be taken into consideration.

NUTRITIONAL NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

Therapeutic effect of implanted and non-invasive vagus nerve stimulation on heroin-induced anxiety

Yingbiao Yue et al.

Summary: Substance addiction leads to anxiety, reinforcing the cycle of substance use and making addiction difficult to cure. This study tested whether vagus nerve stimulation (VNS) could improve heroin-induced anxiety and compared the effects of transcervical vagus nerve stimulation (nVNS) and transauricular vagus nerve stimulation (taVNS) on therapeutic outcomes.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Review Medicine, Research & Experimental

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

Jonathon C. Arnold et al.

Summary: Global interest in CBD is increasing, with clinical trial evidence supporting high doses for treating childhood epilepsies. However, the therapeutic benefits of low-dose CBD products are still being debated. This review evaluated the efficacy and safety of low oral doses of CBD and found that doses of 300 mg or higher showed evidence of reducing anxiety and anti-addiction effects, but the effects on insomnia, neurological disorders, and chronic pain were limited and inconsistent.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Clinical Neurology

Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: A real-world retrospective study

Javier Pena-Ceballos et al.

Summary: Cenobamate has been shown to significantly improve seizure control in highly active and ultra-refractory focal epilepsy patients. However, adverse events may occur at doses above 250 mg/day, limiting further improvements in seizure control.

EPILEPSIA (2023)

Review Biochemistry & Molecular Biology

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

Nicholas Pintori et al.

Summary: Cannabis is widely used as a drug of abuse globally, with Delta 9-tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most abundant phytocannabinoids in the plant. Despite their similar chemical structures, THC is psychoactive while CBD has anxiolytic and antipsychotic properties by binding to the same receptors. CBD and THC-based products have become popular in the food and health industry, and cannabis use has been legalized in many regions. However, the long-term effects of CBD exposure, especially during adolescence, are still not well understood. This review aims to gather preclinical and clinical evidence on the effects of cannabidiol.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Chemistry, Multidisciplinary

AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges

Lin Kang et al.

Summary: In recent years, adeno-associated virus (AAV) has become the most important vector for central nervous system (CNS) gene therapy. AAV has shown promising results in treating CNS diseases that cannot be treated with drugs. This review summarizes the therapeutic progress, challenges, limitations, and solutions for AAV-based gene therapy in 14 types of CNS diseases.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Medicine, General & Internal

Balancing potential benefits and ethical considerations of gene editing

Shampa Ghosh et al.

LANCET (2023)

Review Clinical Neurology

Drug resistance in epilepsy

Emilio Perucca et al.

Summary: Drug resistance affects about a third of people with epilepsy, and its prevalence varies depending on the epilepsy syndrome, cause, age of seizure onset, and neurological deficits. After two failed attempts with antiseizure medications, individuals should be referred to a comprehensive epilepsy centre for re-evaluation and targeted management. Delay in finding an effective treatment can negatively impact outcome and increase the risk of cognitive disability, comorbidities, and premature mortality.

LANCET NEUROLOGY (2023)

Article Clinical Neurology

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Drug-Resistant Epilepsy in the MORE Multicenter Patient Registry

Jukka Peltola et al.

Summary: The MORE registry provides real-world evidence that deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is effective and safe in reducing seizure frequency in patients with drug-resistant epilepsy. The study also suggests that the volume of surgeries performed at the center may affect treatment outcomes.

NEUROLOGY (2023)

Article Clinical Neurology

Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial

Huajun Yang et al.

Summary: This study investigated the effectiveness and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in patients with epilepsy. The patients were divided into an active stimulation group and a control group. The results showed that the responder rate and reduction in seizure frequency were significantly higher in the active group compared to the control group at 20 weeks of stimulation. No significant differences were observed in quality of life, mood, and cognitive state scores. The main adverse events were pain, sleep disturbance, flu-like symptoms, and local skin discomfort, which were similar between the two groups. Ta-VNS was found to be an effective and safe therapy for epilepsy, but further research is needed to validate its benefits in improving quality of life, mood, and cognitive state.

NEUROTHERAPEUTICS (2023)

Article Pharmacology & Pharmacy

Ketogenic diet in children and adolescents: The effects on growth and nutritional status

Antonio Corsello et al.

Summary: The ketogenic diet has been increasingly used for weight loss among adolescents and young adults due to its supposed effects on lipolysis and insulin levels. However, there is still a lack of clear indications on its use for weight loss in pediatric age. It has also been proposed for other disorders like inherited metabolic disorders, Prader-Willi syndrome, and certain types of cancers. A clinical evaluation of possible side effects, growth, and nutritional status is essential for patients following a long-term restrictive diet like the ketogenic one.

PHARMACOLOGICAL RESEARCH (2023)

Article Engineering, Biomedical

Closed-loop optogenetic control of the dynamics of neural activity in non-human primates

B. Zaaimi et al.

Summary: Closed-loop optogenetic stimulation with excitatory opsins enables precise manipulation of neural dynamics in brain slices and non-human primates, with potential therapeutic applications in humans.

NATURE BIOMEDICAL ENGINEERING (2023)

Article Acoustics

EVALUATION OF NON-INVASIVE OPTOGENETIC STIMULATION WITH TRANSCRANIAL FUNCTIONAL ULTRASOUND IMAGING

Christian Aurup et al.

Summary: This study explores a fully non-invasive combined technique using focused ultrasound and functional ultrasound imaging for optogenetics in mice. It successfully delivers viral vectors encoding light-sensitive ion channels and detects stimulus-evoked cerebral blood volume changes. It can serve as a valuable tool for neuroscience research in small animals.

ULTRASOUND IN MEDICINE AND BIOLOGY (2023)

Article Multidisciplinary Sciences

A pilot study of closed-loop neuromodulation for treatment-resistant post-traumatic stress disorder

Jay L. Gill et al.

Summary: In this pilot study, the authors recorded neurophysiological data in two male individuals with treatment-resistant post-traumatic stress disorder (TR-PTSD) over the course of one year. They found that amygdala theta activity was heightened during aversive and symptomatic experiences, and reduced following significant clinical improvement associated with closed-loop stimulation.

NATURE COMMUNICATIONS (2023)

Review Green & Sustainable Science & Technology

The Sustainability of Industrial Hemp: A Literature Review of Its Economic, Environmental, and Social Sustainability

Gurinder Kaur et al.

Summary: Industrial hemp, with its various forms, such as fiber, food, and oil, has the potential to address the climate crisis as a sustainable and versatile plant. The ban on industrial hemp production in the U.S. has been lifted recently, leading to a significant increase in its popularity, which can be attributed to its sustainability potential. This study fills a knowledge gap regarding the sustainable potential of hemp as a crop.

SUSTAINABILITY (2023)

Review Neurosciences

Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation

Sahithi Madireddy et al.

Summary: Epilepsy is a central nervous system disorder that affects 50 million people globally, and developing new therapeutic strategies is important due to drug resistance. Oxidative stress, mitochondrial dysfunction, and neuroinflammation play significant roles in the development of epilepsy. This review discusses the pathophysiology of epilepsy and various treatment options including medication, anti-inflammatory therapies, antioxidant therapies, neuromodulation, surgery, and dietary strategies like the ketogenic diet.

BRAIN SCIENCES (2023)

Article Neurosciences

Brain-clinical signatures for vagus nerve stimulation response

Zhihao Guo et al.

Summary: This study aimed to explore the correlations of brain-clinical signatures with the clinical phenotype and VNS responsiveness in drug-resistant epilepsy patients. Results showed a higher seizure reduction in the VNS-treated group and abnormal imaging representation was commonly observed in this group. The brain-clinical signature illustrated its clinical potential in predicting the VNS response.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Review Health Care Sciences & Services

Landscape and future directions of machine learning applications in closed-loop brain stimulation

Anirudha S. Chandrabhatla et al.

Summary: Brain stimulation (BStim) includes various modalities that use implanted electrodes in deep brain structures to treat neurological disorders. BStim is primarily used for movement disorders like Parkinson's, but is expanding to include neuropsychiatric disorders. Advancements in BStim have led to closed-loop systems that adjust stimulation based on neural biomarkers, using machine learning (ML) algorithms to predict disease symptoms. ML has been successfully utilized in developing closed-loop systems for epilepsy, movement disorders, and neuropsychiatric disorders.

NPJ DIGITAL MEDICINE (2023)

Article Clinical Neurology

Synergistic effects of vagus nerve stimulation and antiseizure medication

Yaroslav Winter et al.

Summary: This study aimed to identify the synergistic effects between VNS and different ASMs. The results showed that the combination of VNS with SV2A modulators or slow sodium channel inhibitors was associated with a better seizure reduction compared to other mechanisms of action. These preliminary data require further validation under controlled conditions.

JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Optogenetics for controlling seizure circuits for translational approaches

Marco Ledri et al.

Summary: The advent of optogenetic tools has revolutionized our understanding of the brain by offering precise manipulation of neurons with temporal precision. In epilepsy research, these tools have played a crucial role in understanding seizure generation and exploring therapeutic strategies. They have provided insights into the initiation of seizures, interactions between different brain regions, and potential for real-time control of seizure activity.

NEUROBIOLOGY OF DISEASE (2023)

Review Pharmacology & Pharmacy

Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?

J. Maia et al.

Summary: Cannabinoids in cannabis, such as THC and CBD, have potential therapeutic benefits for various medical conditions. The endocannabinoid system, which includes CB1 and CB2 receptors, regulates physiological and cognitive processes and may be a therapeutic target for health conditions. Synthetic cannabinoids are also being explored for pharmacological use. Cannabinoids may affect angiogenesis and have potential in treating angiogenesis-related diseases.

BIOCHEMICAL PHARMACOLOGY (2023)

Article Multidisciplinary Sciences

Lived experiences of caregivers of persons with epilepsy attending an epilepsy clinic at a tertiary hospital, eastern Uganda: A phenomenological approach

Lindah Okiah et al.

Summary: The purpose of this study was to determine the lived experiences of caregivers of persons with epilepsy in Uganda. Through face-to-face interviews, it was found that caregivers mostly perceived epilepsy as a burden, including psychological, social, economic, and physical burdens. It is recommended to develop services and plans that comprehensively manage epilepsy considering the burden faced by caregivers.

PLOS ONE (2023)

Review Clinical Neurology

The intralaminar thalamus: a review of its role as a target in functional neurosurgery

Hisse Arnts et al.

Summary: Arnts et al. discuss the role of the intralaminar thalamus as a strategic node in different basal ganglia-thalamocortical networks. This region plays a key role in modulating disease networks associated with pain, epilepsy, Tourette syndrome, Parkinson's disease, and disorders of consciousness. The intralaminar thalamus regulates information transmission in cortical circuits, participating in various functions such as cognition, arousal, consciousness, and pain processing. It has been targeted for surgical ablation and deep brain stimulation (DBS) in neurological and psychiatric disorders.

BRAIN COMMUNICATIONS (2023)

Review Oncology

The Role of Ketogenic Diet in the Treatment of Neuroblastoma

Rangarirai Makuku et al.

Summary: The ketogenic diet was originally used for drug-resistant epileptic patients and has since been studied for its therapeutic potential in various diseases. However, its effectiveness as an antitumor nutritional therapy for Neuroblastoma remains uncertain.

INTEGRATIVE CANCER THERAPIES (2023)

Article Neurosciences

The neuropharmacology of cannabinoid receptor ligands in central signaling pathways

Tibor M. Brunt et al.

Summary: The endocannabinoid system is a complex neuronal system involved in various biological functions, and its understanding has been driven by the potential therapeutic benefits of cannabinoid ligands. This review provides an overview of the neuropharmacology of cannabinoid receptor ligands, including endocannabinoids, herbal cannabis, and synthetic cannabinoids, focusing on their modulatory actions through other neurotransmitter systems. The effects of cannabinoid ligands on neurotransmitter systems such as dopamine, serotonin, glutamate, noradrenaline, opioid, and GABA are discussed, as well as their therapeutic potential and adverse effects.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Review Medicine, Research & Experimental

Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms

Badrinathan Sridharan et al.

Summary: The ketogenic diet and ketone bodies have gained attention for their potential to influence energy metabolism and stabilize mitochondrial homeostasis. They have shown therapeutic benefits for several metabolic diseases, especially Alzheimer's disease. Stabilizing mitochondrial energy metabolism is a crucial mechanism of action for ketone bodies.

CURRENT MOLECULAR MEDICINE (2022)

Review Clinical Neurology

Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis

Francesco Pizzo et al.

Summary: This systematic review and meta-analysis examined the efficacy of the ketogenic diet in reducing seizure frequency in children. The results showed that the ketogenic diet significantly reduces seizures in children with drug-resistant epilepsy, making it an effective treatment option for this population.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2022)

Review Nanoscience & Nanotechnology

A review on magnetic and spintronic neurostimulation: challenges and prospects

Renata Saha et al.

Summary: This article reviews the use of electrical probes and arrays in the treatment of neurodegenerative, sensory, and cardiovascular diseases. It discusses the limitations of current techniques and introduces micromagnetic stimulation as a promising alternative. The review also highlights the features and potential applications of magnetic neurostimulators, including microcoils, spintronic nanodevices, and magnetic nanoparticles.

NANOTECHNOLOGY (2022)

Review Pharmacology & Pharmacy

The current use and evolving landscape of nutraceuticals

Avijeet S. Chopra et al.

Summary: The nutraceutical market is a multi-billion-dollar industry with significant impact, expected to grow rapidly in the future. Market opportunities and regulations drive industry development, though challenges exist in regulatory and definitional coherence internationally.

PHARMACOLOGICAL RESEARCH (2022)

Article Clinical Neurology

VNS parameters for clinical response in Epilepsy

Firas Fahoum et al.

Summary: This study identifies a target dose for VNS therapy in epilepsy based on clinical outcomes and specific dosing parameters. It also highlights the potential benefit of achieving the target dose for patients with shorter duration of epilepsy. Aligning clinical practice with the evidence-based target dose can improve VNS outcomes.

BRAIN STIMULATION (2022)

Review Biology

Machine learning in medical applications: A review of state-of-the-art methods

Mohammad Shehab et al.

Summary: Machine learning methods have been extensively applied in the medical field to enhance the reliability and accuracy of diagnostic systems. This survey provides a comprehensive review of the standard technologies and discusses five major medical applications of machine learning.

COMPUTERS IN BIOLOGY AND MEDICINE (2022)

Article Behavioral Sciences

Safety and efficacy of responsive neurostimulation in the pediatric population: Evidence from institutional review and patient-level meta-analysis

Panagiotis Kerezoudis et al.

Summary: RNS shows promising safety and efficacy in reducing seizure frequency in pediatric patients with drug-resistant epilepsy, although further randomized controlled trials are needed for definitive conclusions.

EPILEPSY & BEHAVIOR (2022)

Review Neurosciences

Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches

Gareth Morris et al.

Summary: Gene therapy is showing promise in treating rare monogenetic neurological disorders and could potentially offer new treatments for common non-genetic disorders as well. However, the permanent nature of gene therapies may pose risks, and research is being conducted to develop approaches that allow for treatment to be turned on and off.

NEUROSCIENCE (2022)

Review Clinical Neurology

Integrating Network Neuroscience Into Epilepsy Care: Progress, Barriers, and Next Steps

Nishant Sinha et al.

Summary: Drug resistant epilepsy is a disorder involving widespread brain network alterations. Neuroimaging and electrophysiology network analysis techniques have shown promise in aiding medical management, but they are not yet used clinically or influencing medical and surgical decisions.

EPILEPSY CURRENTS (2022)

Review Clinical Neurology

An Interplay Between Post-Traumatic Epilepsy and Associated Cognitive Decline: A Systematic Review

Irma Wati Ngadimon et al.

Summary: This systematic review examines the relationship between PTE and cognitive impairment in TBI patients and suggests a possible link between the two. However, due to variations in sample sizes, follow-up periods, and assessment tools, the interpretation and significance of this relationship are limited.

FRONTIERS IN NEUROLOGY (2022)

Review Clinical Neurology

Towards network-guided neuromodulation for epilepsy

Rory J. Piper et al.

Summary: Epilepsy is a disorder of brain networks, and researchers are identifying critical nodes within these networks to target therapies for seizures. Intracranial neuromodulation has proven effective in reducing seizures in both adults and children, and the convergence of these fields is driving a new era of network-guided neuromodulation for epilepsy. This review summarizes the current literature on network mechanisms underlying neurostimulation for epilepsy, focusing on key propagation points in the epileptogenic network. The authors discuss current clinical targets, such as the thalamic nuclei, as well as emerging targets like the pulvinar of the thalamus and the cerebellum. They also report on findings from various modalities of investigation, including EEG and MRI, that reveal the structural and functional networks associated with these propagation points. The authors emphasize the importance of using network analyses to determine patient eligibility for neurostimulation and delivering personalized stimulation based on individual epileptogenic networks.

BRAIN (2022)

Article Clinical Neurology

Anterior nucleus of the thalamus deep brain stimulation vs temporal lobe responsive neurostimulation for temporal lobe epilepsy

Jimmy C. Yang et al.

Summary: We compared the effects of THL-DBS and TL-RNS in patients with drug-resistant TLE and found that both methods have similar outcomes.

EPILEPSIA (2022)

Review Clinical Neurology

Evidence supporting deep brain stimulation of the medial septum in the treatment of temporal lobe epilepsy

Eric R. Cole et al.

Summary: Electrical brain stimulation is an effective treatment option for epilepsy patients who do not respond to medication. Stimulation of the medial septum can reduce seizure frequency and restore cognitive comorbidities associated with epilepsy.

EPILEPSIA (2022)

Article Multidisciplinary Sciences

Closed-loop direct control of seizure focus in a rodent model of temporal lobe epilepsy via localized electric fields applied sequentially

Wonok Kang et al.

Summary: Direct electrical stimulation of the seizure focus can terminate epileptic oscillations, but intervening the hippocampus is challenging. In this study, a sequential narrow-field stimulation method was used to terminate seizures in a rat model with spatially extensive hippocampal structure. The results demonstrate the selectiveness and preciseness of this method, suggesting its potential as a therapeutic approach.

NATURE COMMUNICATIONS (2022)

Article Neurosciences

Responsive Neurostimulation of the Thalamus for the Treatment of Refractory Epilepsy

Jorge A. Roa et al.

Summary: This study evaluated the efficacy of the NeuroPace Responsive Neurostimulation System (NMS) in the treatment of refractory epilepsy. The results showed that NMS could achieve seizure control in approximately 65% of patients. Infections were the most common complication.

FRONTIERS IN HUMAN NEUROSCIENCE (2022)

Review Nutrition & Dietetics

Ketogenic Diets in the Management of Lennox-Gastaut Syndrome-Review of Literature

Urszula Skrobas et al.

Summary: Epilepsy is a global medical problem with a significant number of patients. Ketogenic dietary therapies have shown efficacy and safety in reducing seizures, especially in patients with Lennox-Gastaut syndrome (LGS).

NUTRIENTS (2022)

Review Biochemistry & Molecular Biology

Immunity, Ion Channels and Epilepsy

Tsang-Shan Chen et al.

Summary: Epilepsy is a common chronic neurological disorder in modern society. The immunological factors and the interaction between ion channels and the immune system play important roles in the development and progression of epilepsy. Recognizing immune-mediated epilepsy and understanding the pathophysiology are crucial for early intervention and effective treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cell Biology

Molecular networks underlying cannabinoid signaling in skeletal muscle plasticity

Sebastiaan Dalle et al.

Summary: The cannabinoid system plays a crucial role in neural and immunity processes, as well as in whole body and tissue metabolism. It is regulated by receptor-independent and -dependent mechanisms, impacting skeletal muscle plasticity and physiology. Further research is needed to explore how targeting the cannabinoid system can improve muscle quantity and quality in various conditions.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

Review Pharmacology & Pharmacy

Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy

Keti Bardhi et al.

Summary: This review explores the potential drug-drug interactions (DDI) that may occur with the concomitant use of cannabis and pharmaceuticals. Current research suggests that cannabis has the potential to induce DDI, particularly in major drug-metabolizing enzymes such as cytochrome P450s, carboxylesterases, and uridine-5'-diphosphoglucuronosyltransferases.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)

Article Multidisciplinary Sciences

Treatment of epilepsy using a targeted p38y kinase gene therapy

Nicolle Morey et al.

Summary: Hyperphosphorylated tau protein is involved in various neurological disorders, while site-specific phosphorylation of tau at T205 by p38y kinase can protect against Alzheimer's disease. Delivery of p38y through gene transfer reduces seizure susceptibility, restores normal neuronal activity, improves behavioral deficits, and prevents epilepsy-induced deaths. Additionally, p38y-mediated phosphorylation of tau at T205 plays a crucial role in protecting against epilepsy.

SCIENCE ADVANCES (2022)

Review Neurosciences

Optogenetics at the presynapse

Benjamin R. Rost et al.

Summary: This review provides a comprehensive overview of the presynaptic applications of optogenetic tools, discussing the challenges, limitations, and future directions. Optogenetic actuators enable precise control of presynaptic functions, such as light-mediated neurotransmitter release, presynaptic inhibition, induction of synaptic plasticity, and manipulation of individual components of the presynaptic machinery.

NATURE NEUROSCIENCE (2022)

Review Clinical Neurology

Systematic Review and Meta-Analysis of Responsive Neurostimulation in Epilepsy

Dorian M. Kusyk et al.

Summary: A meta-analysis of recent literature on RNS for DRE shows comparable seizure reduction and responder rates to other neuromodulatory implants for epilepsy, highlighting the value of this intervention and the need for further research. However, the analysis also reveals a strong publication bias towards positive outcomes, indicating the limitations of the current literature. Promising RNS data for the treatment of DRE should be interpreted cautiously.

WORLD NEUROSURGERY (2022)

Review Clinical Neurology

Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies

Kimberly Goodspeed et al.

Summary: Genetic epilepsies are disorders caused by inherited or de novo genetic variants, disrupting brain development and function. Despite current therapies, many patients fail to control their seizures. Advances in gene sequencing and therapy offer new possibilities for treatment of these conditions.

FRONTIERS IN NEUROLOGY (2022)

Review Cell Biology

Optogenetic Methods to Investigate Brain Alterations in Preclinical Models

Marco Brondi et al.

Summary: Research on model organisms allows for better understanding of neurological disorders by linking symptoms to cellular and circuit alterations, with optical approaches and genetic engineering revolutionizing investigation methods for brain diseases.

CELLS (2022)

Review Clinical Neurology

Neuromodulation in drug-resistant epilepsy: A review of current knowledge

Tao Xue et al.

Summary: This article provides a narrative review of three approved neuromodulation therapies for drug-resistant epilepsy, including vagus nerve stimulation (VNS), deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS), and closed-loop responsive neurostimulation (RNS). Although these treatments have shown promising results in reducing seizure frequency and duration, there are still challenges to be addressed, such as heterogeneity among epilepsy types, optimization of stimulation parameters, and a lack of biomarkers to predict response to neuromodulation therapies.

ACTA NEUROLOGICA SCANDINAVICA (2022)

Review Genetics & Heredity

Mechanisms Underlying Circuit Dysfunction in Neurodevelopmental Disorders

David Exposito-Alonso et al.

Summary: Recent advances in genomics have revealed the genetic variations associated with neurodevelopmental disorders, indicating the importance of synaptic formation and circuit balance in these disorders. This review summarizes the research progress on synaptic and circuit mechanisms implicated in neurodevelopmental disorders and discusses the disruptions in synaptic connections and imbalances in neuronal circuits that contribute to cognitive and behavioral changes in different disorders. Furthermore, new approaches that can restore or mitigate dysfunctional processes and the development of improved clinical biomarkers and strategies for early intervention are highlighted.

ANNUAL REVIEW OF GENETICS (2022)

Review Neurosciences

Vagus nerve stimulation for the treatment of epilepsy: things to note on the protocols, the effects and the mechanisms of action

Auwal Abdullahi et al.

Summary: This article discusses non-pharmacological methods for managing epilepsy, including vagus nerve stimulation techniques. It suggests that respiratory vagal nerve stimulation may be an effective non-invasive technique worth considering.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Pilot study of responsive nucleus accumbens deep brain stimulation for loss-of-control eating

Rajat S. Shivacharan et al.

Summary: In this pilot study, responsive deep brain stimulation (DBS) was used to improve self-control of food intake and weight loss in two patients with binge eating disorder (BED) and severe obesity. Increased low-frequency oscillations in the nucleus accumbens (NAc), recorded during food cravings preceding loss of control (LOC) eating, were used to guide the delivery of DBS. Over 6 months, improved self-control of food intake and weight loss were observed. Further research with larger sample sizes is needed to determine the scalability of this approach.

NATURE MEDICINE (2022)

Review Neurosciences

Large-scale, closed-loop interrogation of neural circuits underlying cognition

Dion Khodagholy et al.

Summary: This article reviews the application of closed-loop neurostimulation in cognitive processes. Cognitive functions involve coordinated activity patterns between multiple brain regions, and their disruption by neuropsychiatric disorders is complex. How to effectively identify and target distributed neural networks implicated in mediating cognition through closed-loop neurostimulation remains unclear. The article proposes that devices enabling large-scale acquisition, integrated processing, and multiregion, arbitrary waveform stimulation will be critical for mechanistically driven manipulation of cognitive processes in physiological and pathological brain networks.

TRENDS IN NEUROSCIENCES (2022)

Article Nutrition & Dietetics

Modified Atkins diet versus ketogenic diet in children with drug-resistant epilepsy: A meta-analysis of comparative studies

Asmaa Mhanna et al.

Summary: This meta-analysis compared the efficacy and tolerability of the modified Atkins diet (MAD) and traditional ketogenic diet (KD) in children with drug-resistant epilepsy (DRE). The results showed that traditional KD was superior to MAD in achieving more than 50% reduction in seizure frequency at 6 months. However, there was no significant difference between KD and MAD in achieving more than 90% reduction in seizure frequency or seizure freedom at 6 months. The tolerability profiles of both regimens were similar as well.

CLINICAL NUTRITION ESPEN (2022)

Review Clinical Neurology

Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy

Alok Singh

Summary: This article reviews the efficacy, safety, and tolerability of Cenobamate in treating partial-onset seizures. The findings suggest that Cenobamate, compared to placebo, significantly reduces seizure frequency and increases the number of participants with reduced seizure frequency and adverse effects. However, multiple drug-drug interactions remain a concern.

JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2022)

Review Biochemistry & Molecular Biology

Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations

Huiyuan Zhu et al.

Summary: The ketogenic diet (KD) is a high-fat, adequate-protein, and very-low-carbohydrate diet that has shown therapeutic potential for various diseases. This review summarizes the evidence of its efficacy and safety, discusses the possible mechanisms of action, and suggests the need for randomized controlled trials to support its clinical use.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Engineering, Biomedical

The RNS System: brain-responsive neurostimulation for the treatment of epilepsy

Beata Jarosiewicz et al.

Summary: This review discusses the NeuroPace RNS System, the only brain-responsive neurostimulation device, and the results of multi-year clinical trials. Brain-responsive neurostimulation has the potential to be used for treating episodic neurological disorders with a neurophysiological biomarker of severity, and combining advanced machine learning with chronic ambulatory brain data collected by the RNS System could lead to personalized treatment for each patient.

EXPERT REVIEW OF MEDICAL DEVICES (2021)

Review Clinical Neurology

Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome

Simona Lattanzi et al.

Summary: Pharmaceutically purified oral cannabidiol (CBD) has been approved for treating seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), showing efficacy in managing symptoms such as somnolence, gastrointestinal discomfort, and increase in serum transaminases. CBD's metabolism in the liver can influence drug metabolism enzymes, particularly in interactions with antiseizure medications like clobazam. The findings pertain specifically to high-grade purified CBD oral solution and may not be applicable to other cannabis-based products.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)

Article Plant Sciences

Cognition and memory impairment attenuation via reduction of oxidative stress in acute and chronic mice models of epilepsy using antiepileptogenic Nux vomica

Priya Mishra et al.

Summary: The study explored the anticonvulsant and antiepileptogenic potential of Nux vomica homeopathic medicinal preparations in acute and chronic seizure models, showing promising results in improving cognitive and memory function, reducing motor impairment, and alleviating oxidative stress in kindled animals. The findings suggest that further investigation into the cellular and molecular mechanisms of these preparations is warranted.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Article Behavioral Sciences

Efficacy of Cicuta virosa medicinal preparations against pentylenetetrazole-induced seizures

Priya Mishra et al.

Summary: Homeopathic medicinal preparations (HMPs) of Cicuta virosa (CV) show promising therapeutic potential in experimental models of epilepsy, modulating neurotransmission and improving cognitive function. By reducing oxidative stress load, CV HMPs also demonstrate a role in enhancing free radical scavenging mechanism.

EPILEPSY & BEHAVIOR (2021)

Review Biochemical Research Methods

Neural interface systems with on-device computing: machine learning and neuromorphic architectures

Jerald Yoo et al.

Summary: The development of neural interface and brain-machine interface systems has opened up new possibilities for treating various neurological disorders through the integration of artificial intelligence and machine learning. This trend towards combining advanced technologies will lead to the creation of low-power, smart, and miniaturized therapeutic devices for a wide range of neurological and psychiatric disorders.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Review Clinical Neurology

Technology of deep brain stimulation: current status and future directions

Joachim K. Krauss et al.

Summary: Deep brain stimulation (DBS) is a neurosurgical procedure that allows targeted circuit-based neuromodulation and is now commonly used for the treatment of movement disorders such as Parkinson's disease, tremor, and dystonia. Advances in engineering and imaging technologies are expected to enhance the efficacy and tolerability of DBS procedures in the future.

NATURE REVIEWS NEUROLOGY (2021)

Article Medicine, Research & Experimental

Surgical and Hardware Complications of Deep Brain Stimulation-A Single Surgeon Experience of 519 Cases Over 20 Years

Paresh K. Doshi et al.

Summary: This study analyzed the risk factors for complications in deep brain stimulation (DBS) surgery and found that the complication rate decreases with cumulative years of experience, demonstrating a learning curve effect.

NEUROMODULATION (2021)

Review Neurosciences

NPY and Gene Therapy for Epilepsy: How, When, ... and Y ...

Stefano Cattaneo et al.

Summary: Neuropeptide Y is a pleiotropic molecule that influences cell proliferation, cardiovascular and metabolic function, pain, and neuronal excitability, with potential anti-epileptic effects. Overexpression of NPY in the brain with viral vectors can suppress seizures in animal models of epilepsy, suggesting a novel approach for epilepsy treatment. However, further research is needed to fully understand the therapeutic potential of NPY-based gene therapy for epilepsy.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Clinical Neurology

Responsive Vagus Nerve Stimulation for Drug Resistant Epilepsy: A Review of New Features and Practical Guidance for Advanced Practice Providers

Breanne Fisher et al.

Summary: Vagus nerve stimulation (VNS) is a safe and effective therapy for drug resistant epilepsy that has been available for over 20 years. The therapy has evolved to provide advanced features and closed-loop stimulation, and dedicated VNS clinics managed by Advanced Practice Providers (APPs) have improved access and continuity of care for patients. APPs play an integral role in comprehensive healthcare teams, providing guidance and support for those managing VNS patients.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Closed-loop stimulation of the medial septum terminates epileptic seizures

Yuichi Takeuchi et al.

Summary: The study demonstrates that closed-loop electrical stimulation of the medial septum can effectively terminate intrahippocampal seizures and suppress secondary generalization, emphasizing the importance of internally driven stimulus timing. By precisely activating medial septum GABAergic neurons, successful intervention in pathological oscillations was achieved, providing a new avenue for future clinical translation in other neurological and psychiatric disorders.

BRAIN (2021)

Review Neurosciences

Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research

Valentina Franco et al.

Summary: CBD has shown therapeutic potential in seizure disorders, with progress made in understanding its mechanisms of action and clinical properties. A pharmaceutical-grade formulation of purified CBD has been approved for treatment in certain seizure syndromes, but interactions with other medications, such as clobazam, remain a complex issue. Despite advances, there are still significant gaps in knowledge regarding CBD's antiseizure activity.

NEUROPHARMACOLOGY (2021)

Review Psychology, Biological

The dynamic regulation of appetitive behavior through lateral hypothalamic orexin and melanin concentrating hormone expressing cells

Jenna Lee et al.

Summary: The lateral hypothalamic area (LHA) plays a crucial role in regulating energy balance through coordination of feeding behavior mainly by Orexin (ORX) and Melanin Concentrating Hormone (MCH) cell populations. These two systems support feeding behavior through different mechanisms, interact with other neuropeptides and reward systems, and regulate appetite by transitioning between different appetitive states.

PHYSIOLOGY & BEHAVIOR (2021)

Review Clinical Neurology

Effects of the COVID-19 pandemic on medication adherence: In the case of antiseizure medications, A scoping review

Sonia Menon et al.

Summary: The global health emergency caused by the COVID-19 pandemic has had a negative impact on medication adherence among people with epilepsy, highlighting the need for more research. A literature scoping review identified key issues in ASM adherence, such as lack of follow-up and difficulties accessing medications, calling for a more comprehensive chronic disease model to be established.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)

Review Nanoscience & Nanotechnology

Targeted drug delivery strategies for precision medicines

Mandana T. Manzari et al.

Summary: Precision medicine offers personalized treatment strategies for individual patients, especially in the field of cancer therapy. While there have been some clinical successes, challenges such as drug toxicities and resistance still hinder the full potential of precision medicine. Advanced drug delivery materials and approaches provide opportunities to improve therapeutic outcomes and overcome pharmacological issues in cancer treatment.

NATURE REVIEWS MATERIALS (2021)

Review Clinical Neurology

Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome

Simona Lattanzi et al.

Summary: CBD, a major constituent of the Cannabis sativa plant, has been approved by the US FDA and EMA for the treatment of seizures. Studies have shown that a highly purified oral formulation of CBD can be effective in treating a broad range of epilepsy disorders beyond Dravet syndrome and Lennox-Gastaut syndrome.

CNS DRUGS (2021)

Review Neurosciences

Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord

Thomas Leth Jensen et al.

Summary: In recent years, gene therapy has advanced in the treatment of rare genetic diseases, particularly those affecting the brain and spinal cord such as spinal muscular atrophy and metachromatic leukodystrophy. These successes may indicate the emergence of more new gene therapies in the future.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Behavioral Sciences

Precision medicine in women with epilepsy: The challenge, systematic review, and future direction

Yi Li et al.

Summary: Epilepsy is a common neurological condition that affects nearly 70 million people globally. Women with epilepsy face gender-specific challenges and precision medicine may offer tailored management solutions.

EPILEPSY & BEHAVIOR (2021)

Review Pharmacology & Pharmacy

Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?

Leontina Elena Filipiuc et al.

Summary: The discovery of the pharmacological effects of cannabis, traditionally used in Asia, has led to the development of new compounds for treating various diseases. Recent research suggests that these effects may not only involve cannabinoid receptors, but also other mechanisms yet to be fully understood.

PHARMACEUTICS (2021)

Review Neurosciences

Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases

Bruno Bonaz et al.

Summary: The vagus nerve has dual anti-inflammatory properties and may be used in the treatment of chronic inflammatory bowel diseases. Its activation can inhibit the release of tumor necrosis factor (TNF) alpha by various mechanisms, making it a potential non-drug therapeutic approach.

FRONTIERS IN NEUROSCIENCE (2021)

Article Psychiatry

Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval

Lora Kahn et al.

Summary: This study demonstrated the effectiveness of deep brain stimulation (DBS) in treating obsessive-compulsive disorder (OCD) even in patients with comorbidities. Patients with various comorbid diseases showed significant improvement in OCD symptoms through DBS therapy, emphasizing the importance of accurate electrode placement and programming strategies.

FRONTIERS IN PSYCHIATRY (2021)

Review Biochemistry & Molecular Biology

Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy

Shampa Ghosh et al.

Summary: Epilepsy is a common chronic brain disorder affecting people of all ages, accompanied by various health issues. Understanding the mechanisms and treatment of epilepsy is crucial for improving the quality of life for patients.

BIOMEDICINES (2021)

Article Engineering, Biomedical

A multimodal, implantable sensor array and measurement system to investigate the suppression of focal epileptic seizure using hypothermia

B. Csernyus et al.

Summary: The study demonstrated that cooling the cortical surface to around 20 degrees Celsius efficiently suppresses epileptic discharges, with distant cortical areas also being influenced. This suggests that the efficacy of seizure suppression is not solely determined by the absolute drop in temperature.

JOURNAL OF NEURAL ENGINEERING (2021)

Review Neurosciences

Energy-Efficient Integrated Circuit Solutions Toward Miniaturized Closed-Loop Neural Interface Systems

Jaeouk Cho et al.

Summary: Miniaturized implantable devices are crucial for neural interfaces in monitoring and modulating neural activities. The pursuit of a compact wireless closed-loop system can automatically stimulate nerves based on user conditions, reducing power consumption and side effects. However, challenges in hardware design remain, such as neural activity recording and energy-efficient wireless power delivery.

FRONTIERS IN NEUROSCIENCE (2021)

Article Clinical Neurology

Epilepsy Personal Assistant Device-A Mobile Platform for Brain State, Dense Behavioral and Physiology Tracking and Controlling Adaptive Stimulation

Tal Pal Attia et al.

Summary: Epilepsy is a common neurological disorder affecting approximately 1% of the global population, with many patients continuing to have seizures despite treatment. The unpredictable nature of seizures and associated comorbidities significantly impact quality of life. Seizure predictions and long-term objective data are essential for optimizing treatment.

FRONTIERS IN NEUROLOGY (2021)

Review Clinical Neurology

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies

Antonella Fattorusso et al.

Summary: Epilepsy is a common chronic neurological disorder with a prevalence of 0.5-1%. Most patients can achieve seizure control with medication, but about one-third are drug-resistant, making management challenging.

FRONTIERS IN NEUROLOGY (2021)

Review Clinical Neurology

Emerging Role of the Ketogenic Dietary Therapies beyond Epilepsy in Child Neurology

Dipti Kapoor et al.

Summary: The ketogenic dietary therapies have been successfully used for childhood epilepsy for a century, showing potential benefits in various neurological conditions other than epilepsy such as autism spectrum disorder and Fragile X syndrome. Research in this field is still in the early stages, presenting a wide scope for further studies.

ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Clinical Potential of Nerve Input to Tumors: A Bioelectricity Perspective

Jade A. Phillips et al.

Summary: This article supports the significant role of neural connections and bioelectricity in the tumor microenvironment. While nerve input promotes cancer development, direct surgical denervation of tumors may have unpredictable and irreversible side effects. Using electroceutical approaches, tumor innervation can be effectively manipulated to improve therapeutic outcomes.

BIOELECTRICITY (2021)

Review Engineering, Biomedical

Evolution of the Vagus Nerve Stimulation (VNS) Therapy System Technology for Drug-Resistant Epilepsy

Pegah Afra et al.

Summary: The Vagus Nerve Stimulation (VNS) Therapy System is the first FDA-approved medical device therapy for drug-resistant epilepsy treatment. This technology has evolved over the past two decades with multiple updates, resulting in various generator models with subtle differences that can be challenging for healthcare providers to differentiate without manual comparison.

FRONTIERS IN MEDICAL TECHNOLOGY (2021)

Review Neurosciences

Artificial Intelligence in Epilepsy

Taranjit Kaur et al.

Summary: Research on AI systems for pattern recognition in EEG can assist in more accurate diagnoses, but it is important to note that AI is meant to work alongside doctors rather than replace them, emphasizing the importance of domain knowledge in building robust AI models for real-time scenarios.

NEUROLOGY INDIA (2021)

Review Geriatrics & Gerontology

Neuromodulation in Drug Resistant Epilepsy

Natalia Rincon et al.

Summary: Epilepsy affects millions worldwide, with drug-resistant cases posing a challenge for surgical intervention. Neuromodulation therapies like VNS, RNS, and DBS may offer alternative treatment options for these patients.

AGING AND DISEASE (2021)

Review Clinical Neurology

Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABAA Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications

Dustin R. Latimer et al.

Summary: The medical management of epilepsy aims to reduce seizure frequency and help patients maintain a normal lifestyle, but current drugs have potential side effects. Cenobamate, a newly FDA-approved drug for partial-onset seizures, shows promise in reducing seizures but can cause side effects such as somnolence and dizziness. Ongoing studies are evaluating its long-term benefits and adverse events.

NEUROLOGY INTERNATIONAL (2021)

Review Clinical Neurology

Action of antiepileptic drugs on neurons

Katsuhiro Kobayashi et al.

BRAIN & DEVELOPMENT (2020)

Review Anatomy & Morphology

The anatomical basis for transcutaneous auricular vagus nerve stimulation

Mohsin F. Butt et al.

JOURNAL OF ANATOMY (2020)

Review Pharmacology & Pharmacy

Neuromodulation for the Treatment of Epilepsy: A Review of Current Approaches and Future Directions

Patrick Davis et al.

CLINICAL THERAPEUTICS (2020)

Article Clinical Neurology

Safety of responsive neurostimulation in pediatric patients with medically refractory epilepsy

Fedor Panov et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2020)

Review Pharmacology & Pharmacy

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

Wolfgang Loescher et al.

PHARMACOLOGICAL REVIEWS (2020)

Review Clinical Neurology

Biomarkers of seizure response to vagus nerve stimulation: A scoping review

Adriana M. Workewych et al.

EPILEPSIA (2020)

Review Clinical Neurology

Impact of predictive, preventive and precision medicine strategies in epilepsy

Rima Nabbout et al.

NATURE REVIEWS NEUROLOGY (2020)

Article Clinical Neurology

Centromedian thalamic responsive neurostimulation for Lennox-Gastaut epilepsy and autism

Churl-Su Kwon et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Nicole Jacqueline Jensen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Neurosciences

Role of Neuromodulation for Treatment of Drug-Resistant Epilepsy

Jasmine Parihar et al.

NEUROLOGY INDIA (2020)

Review Biochemistry & Molecular Biology

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Hongyi Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Clinical Neurology

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors

R. Stevelin et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Review Clinical Neurology

A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood

Han Yan et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2019)

Review Clinical Neurology

Deep brain stimulation: current challenges and future directions

Andres M. Lozano et al.

NATURE REVIEWS NEUROLOGY (2019)

Review Neurosciences

Neuron-glia interactions in the pathophysiology of epilepsy

Dipan C. Patel et al.

NATURE REVIEWS NEUROSCIENCE (2019)

Article Pharmacology & Pharmacy

Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation

Arton Baftiu et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Clinical Neurology

Vagus Nerve Stimulation for the Treatment of Epilepsy

Herman F. J. Gonzalez et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2019)

Review Neurosciences

Research progress of vagus nerve stimulation in the treatment of epilepsy

Jing-Jing Fan et al.

CNS NEUROSCIENCE & THERAPEUTICS (2019)

Review Engineering, Biomedical

Neural stimulation systems for the control of refractory epilepsy: a review

Matthew D. Bigelow et al.

JOURNAL OF NEUROENGINEERING AND REHABILITATION (2019)

Article Clinical Neurology

Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy

Michal Tzadok et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)

Article Biochemistry & Molecular Biology

Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

Morgan L. Maeder et al.

NATURE MEDICINE (2019)

Article Medicine, Research & Experimental

Closed-Loop Neuromodulation in Physiological and Translational Research

Stavros Zanos

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)

Review Clinical Neurology

Deep brain stimulation for drug-resistant epilepsy

Michael C. H. Li et al.

EPILEPSIA (2018)

Review Clinical Neurology

Lennox-Gastaut syndrome: a comprehensive review

Ali A. Asadi-Pooya

NEUROLOGICAL SCIENCES (2018)

Review Clinical Neurology

Neocortical electrical stimulation for epilepsy: Closed-loop versus open-loop

Albena Vassileva et al.

EPILEPSY RESEARCH (2018)

Review Medicine, General & Internal

Practical considerations in medical cannabis administration and dosing

Caroline A. MacCallum et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)

Article Engineering, Biomedical

Closed-Loop Vagus Nerve Stimulation Based on State Transition Models

Hector M. Romero-Ugalde et al.

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2018)

Article Neurosciences

Promises and limitations of human intracranial electroencephalography

Josef Parvizi et al.

NATURE NEUROSCIENCE (2018)

Article Medicine, General & Internal

Epilepsy

Orrin Devinsky et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Review Engineering, Biomedical

Recent advances in devices for vagus nerve stimulation

Ann Mertens et al.

EXPERT REVIEW OF MEDICAL DEVICES (2018)

Review Behavioral Sciences

Responsive neurostimulation: Candidates and considerations

Brandy B. Ma et al.

EPILEPSY & BEHAVIOR (2018)

Article Multidisciplinary Sciences

Closed-loop functional optogenetic stimulation

Shriya S. Srinivasan et al.

NATURE COMMUNICATIONS (2018)

Article Clinical Neurology

Responsive neurostimulation for treatment of pediatric drug-resistant epilepsy

Nilika S. Singhal et al.

EPILEPSY & BEHAVIOR CASE REPORTS (2018)

Review Neurosciences

Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy

Chinekwu Anyanwu et al.

BRAIN SCIENCES (2018)

Editorial Material Biochemistry & Molecular Biology

A brief account of viral vectors and their promise for gene therapy

M. Finer et al.

GENE THERAPY (2017)

Review Engineering, Biomedical

Advances in closed-loop deep brain stimulation devices

Mahboubeh Parastarfeizabadi et al.

JOURNAL OF NEUROENGINEERING AND REHABILITATION (2017)

Article Medicine, General & Internal

Neurostimulation Devices for the Treatment of Neurologic Disorders

Christine A. Edwards et al.

MAYO CLINIC PROCEEDINGS (2017)

Review Neurosciences

Integration of optogenetics with complementary methodologies in systems neuroscience

Christina K. Kim et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Review Clinical Neurology

Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients

Maxine Dibue-Adjei et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)

Review Clinical Neurology

New insights into the mechanisms of the ketogenic diet

Detlev Boison

CURRENT OPINION IN NEUROLOGY (2017)

Article Engineering, Biomedical

Seizure Suppression Efficacy of Closed-Loop Versus Open-Loop Deep Brain Stimulation in a Rodent Model of Epilepsy

M. Tariqus Salam et al.

IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2016)

Review Clinical Neurology

Comparing neurostimulation technologies in refractory focal-onset epilepsy

Inuka Kishara Gooneratne et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Multidisciplinary Sciences

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects

Benjamin P. Kleinstiver et al.

NATURE (2016)

Review Clinical Neurology

Cognitive and neurodevelopmental comorbidities in paediatric epilepsy

Katherine C. Nickels et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Medicine, Research & Experimental

Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet

Michael A. Rogawski et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Review Biochemistry & Molecular Biology

CRISPR-mediated genome editing and human diseases

Liquan Cai et al.

GENES & DISEASES (2016)

Review Clinical Neurology

The ketogenic diet in pharmacoresistant childhood epilepsy

Steven Parrish Winesett et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)

Article Clinical Neurology

A roadmap for precision medicine in the epilepsies

F. Berkovic et al.

LANCET NEUROLOGY (2015)

Review Clinical Neurology

Optogenetics and Epilepsy: Past, Present and Future

Jeanne T. Paz et al.

EPILEPSY CURRENTS (2015)

Article Medicine, Research & Experimental

Seizures and Epilepsy: An Overview for Neuroscientists

Carl E. Stafstrom et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

Review Clinical Neurology

The ketogenic diet in pharmacoresistant childhood epilepsy

Steven Parrish Winesett et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)

Article Clinical Neurology

Factors influencing medication adherence after epilepsy surgery

Jianming Liu et al.

EPILEPTIC DISORDERS (2015)

Review Engineering, Biomedical

Electrical Control of Epilepsy

David J. Mogul et al.

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16 (2014)

Review Engineering, Biomedical

Closed loop deep brain stimulation: an evolving technology

Md Kamal Hosain et al.

AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE (2014)

Article Clinical Neurology

ILAE Official Report: A practical clinical definition of epilepsy

Robert S. Fisher et al.

EPILEPSIA (2014)

Review Behavioral Sciences

Seizure detection, seizure prediction, and closed-loop warning systems in epilepsy

Sriram Ramgopal et al.

EPILEPSY & BEHAVIOR (2014)

Review Behavioral Sciences

The consequences of refractory epilepsy and its treatment

Kenneth D. Laxer et al.

EPILEPSY & BEHAVIOR (2014)

Article Clinical Neurology

Gene therapy in epilepsy-is it time for clinical trials?

Dimitri M. Kullmann et al.

NATURE REVIEWS NEUROLOGY (2014)

Review Clinical Neurology

Deep Brain Stimulation for the Treatment of Epilepsy: Circuits, Targets, and Trials

Nealen G. Laxpati et al.

NEUROTHERAPEUTICS (2014)

Review Clinical Neurology

What Happens to Children With Epilepsy When They Become Adults? Some Facts and Opinions

Peter R. Camfield et al.

PEDIATRIC NEUROLOGY (2014)

Editorial Material Clinical Neurology

Responsive Neurostimulation: The Hope and the Challenges

Lara Jehi

EPILEPSY CURRENTS (2014)

Review Behavioral Sciences

Optogenetic strategies to investigate neural circuitry engaged by stress

Dennis R. Sparta et al.

BEHAVIOURAL BRAIN RESEARCH (2013)

Review Cell Biology

Optical developments for optogenetics

Eirini Papagiakoumou

BIOLOGY OF THE CELL (2013)

Review Clinical Neurology

Progress in gene therapy for neurological disorders

Michele Simonato et al.

NATURE REVIEWS NEUROLOGY (2013)

Review Neurosciences

Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction

Ethan M. Goldberg et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Review Neurosciences

Adeno-associated virus (AAV) gene therapy for neurological disease

Marc S. Weinberg et al.

NEUROPHARMACOLOGY (2013)

Article Clinical Neurology

FRONTIERS Surgery of the Mind, Mood, and Conscious State: An Idea in Evolution

R. Aaron Robison et al.

WORLD NEUROSURGERY (2013)

Review Pharmacology & Pharmacy

Host factors affecting antiepileptic drug delivery-Pharmacokinetic variability

Cecilie Johannessen Landmark et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Article Clinical Neurology

Therapeutic devices for epilepsy

Robert S. Fisher

ANNALS OF NEUROLOGY (2012)

Review Neurosciences

Molecular Tools and Approaches for Optogenetics

Yuan Mei et al.

BIOLOGICAL PSYCHIATRY (2012)

Review Behavioral Sciences

Adherence to antiepilepsy drug therapy

Edward Faught

EPILEPSY & BEHAVIOR (2012)

Review Biochemistry & Molecular Biology

Ketone bodies in epilepsy

Melanie A. McNally et al.

JOURNAL OF NEUROCHEMISTRY (2012)

Review Biochemistry & Molecular Biology

Deep brain stimulation in addiction: a review of potential brain targets

J. Luigjes et al.

MOLECULAR PSYCHIATRY (2012)

Review Neurosciences

Optogenetic investigation of neural circuits underlying brain disease in animal models

Kay M. Tye et al.

NATURE REVIEWS NEUROSCIENCE (2012)

Article Multidisciplinary Sciences

Closed-Loop Control of Epilepsy by Transcranial Electrical Stimulation

Antal Berenyi et al.

SCIENCE (2012)

Review Clinical Neurology

Computational models of epilepsy

Roxana A. Stefanescu et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)

Review Neurosciences

The Development and Application of Optogenetics

Lief Fenno et al.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)

Review Clinical Neurology

Obstructive Sleep Apnea and Respiratory Complications Associated with Vagus Nerve Stimulators

Fuzhan Parhizgar et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2011)

Review Clinical Neurology

Overview of the Clinical Applications of Vagus Nerve Stimulation

J. P. Beekwilder et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2010)

Article Clinical Neurology

Current and future indications for deep brain stimulation in pediatric populations

Nir Lipsman et al.

NEUROSURGICAL FOCUS (2010)

Review Clinical Neurology

Gene therapy in epilepsy

Veronique Riban et al.

EPILEPSIA (2009)

Review Behavioral Sciences

Curing epilepsy: Progress and future directions

Margaret P. Jacobs et al.

EPILEPSY & BEHAVIOR (2009)

Review Clinical Neurology

Epileptogenesis in the immature brain: emerging mechanisms

Sanjay N. Rakhade et al.

NATURE REVIEWS NEUROLOGY (2009)

Review Neurosciences

Neural regulation of endocrine and autonomic stress responses

Yvonne M. Ulrich-Lai et al.

NATURE REVIEWS NEUROSCIENCE (2009)

Review Clinical Neurology

CNS adverse events associated with antiepileptic drugs

Gina M. Kennedy et al.

CNS DRUGS (2008)

Review Behavioral Sciences

Modern management of epilepsy: A practical approach

Christian E. Elger et al.

EPILEPSY & BEHAVIOR (2008)

Review Clinical Neurology

Technology insight: neuroengineering and epilepsy - designing devices for seizure control

William C. Stacey et al.

NATURE CLINICAL PRACTICE NEUROLOGY (2008)

Review Clinical Neurology

The neuropharmacology of the ketogenic diet

Adam L. Hartman et al.

PEDIATRIC NEUROLOGY (2007)

Review Medicine, General & Internal

Adult epilepsy

JS Duncan et al.

LANCET (2006)

Article Clinical Neurology

The ketogenic diet: From molecular mechanisms to clinical effects

J Freeman et al.

EPILEPSY RESEARCH (2006)

Review Clinical Neurology

Deep brain stimulation: Postoperative issues

Guenther Deuschl et al.

MOVEMENT DISORDERS (2006)

Review Neurosciences

The neurobiology of antiepileptic drugs

MA Rogawski et al.

NATURE REVIEWS NEUROSCIENCE (2004)

Article Clinical Neurology

Therapeutic mechanisms of vagus nerve stimulation

TR Henry

NEUROLOGY (2002)

Article Clinical Neurology

Some common issues in the use of antiepileptic drugs

JJ Asconape

SEMINARS IN NEUROLOGY (2002)